Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-06-23
1998-12-22
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544354, A61K 31495
Patent
active
058520171
ABSTRACT:
2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3 is hydrogen, C.sub.1 -C.sub.4 -alkyl, phenyl, benzyl or 1-phenylethyl,
REFERENCES:
Corbett et al, Drug Development Research, 24 pp. 201-205, 1991.
Lipton, Tins 16, pp. 527-532, 1993.
Doble, Therapie 50, pp. 319-337, 1995.
Lees, Pharmacology and Pathophysiology 5 pp. 51-74, 1996.
Behl Berthold
Hofmann Hans Peter
Lubisch Wilfried
BASF - Aktiengesellschaft
Bernhardt Emily
LandOfFree
2,3(1H,4H)-quinoxalinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3(1H,4H)-quinoxalinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3(1H,4H)-quinoxalinediones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047925